The patient diagnosed with prostate cancer via PET-MRI imaging was subsequently examined using TRUS-PA and multispectral contrast provided by Hb and ICG was utilized to achieve the imaging depth of up to 3–4 cm. The gene discussed is GSTM1; the disease is prostate carcinoma.